Previous 10 | Next 10 |
2023-05-03 23:07:05 ET Castle Biosciences, Inc. (CSTL) Q1 2023 Earnings Conference Call May 03, 2023 04:30 PM ET Company Participants Camilla Zuckero - Vice President, Investor Relations & Corporate Affairs Derek Maetzold - Founder, President & Chief Executiv...
2023-05-03 17:03:34 ET Castle Biosciences press release ( NASDAQ: CSTL ): Q1 GAAP EPS of -$1.10 misses by $0.21 . Revenue of $42.04M (+56.5% Y/Y) beats by $4.66M . Delivered 14,916 total test reports in the first quarter of 2023, an increase of 73% compared t...
Q1 2023 revenue increased 57% over Q1 2022 to $42 million Q1 2023 total test reports increased 73% over Q1 2022 Reaffirming full-year 2023 revenue is expected to be between $170-180 million Conference call and webcast today at 4:30 p.m. ET Castle Biosciences, Inc...
New independent, multi-center study found that patients who received high-risk DecisionDx-Melanoma test results received routine imaging, which led to earlier detection of recurrences, when the tumor burden was lower, which could result in better clinical outcomes Castle Biosciences...
2023-05-02 17:35:56 ET Major earnings expected after the bell on Wednesday include: QUALCOMM Incorporated ( QCOM ) Realty Income corporation ( O ) MercadoLibre ( MELI ) ETSY ( ETSY ) Fastly ( FSLY ) For further details see: Notable earning...
Thirteen sunscreen dispensers, positioned at rest and lunch stops, will supply sunscreen to the more than 5,200 riders to protect their skin from sunburn during the two-day event Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide pati...
New data shared in a poster presentation during the 19th European Association of Dermato-Oncology (EADO) Congress Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data showing DecisionDx ® ...
Data from patient simulation study to be presented at ESGE (European Society of Gastrointestinal Endoscopy) Days 2023 Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced new data from a patient simulation ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the first quarter ended March 31, 2023, after the close of market on Wednesday, May 3, 2023. Company management ...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that Derek Maetzold, president and chief executive officer, and Frank Stokes, chief financial officer, are scheduled to present a company overview at the 22nd Annu...
News, Short Squeeze, Breakout and More Instantly...
Castle Biosciences Inc. Company Name:
CSTL Stock Symbol:
NASDAQ Market:
Castle Biosciences Inc. Website:
Campaign will focus on empowering patients impacted by melanoma Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, has joined forces with television personality, wellness coach and founder of ALL IN by Teddi, host of the...
Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today announced that it will release its financial results for the second quarter and six months ended June 30, 2024, after the close of market on Monday, Aug. 5, 2024. Compan...
Castle earns recognition as an Arizona Top Workplace, a national Healthcare Industry Top Workplace and receives five Top Workplaces Culture Excellence Awards Castle Biosciences, Inc. (Nasdaq: CSTL), a company improving health through innovative tests that guide patient care, today annou...